In these studies we used U0126 to demonstrate a link between MEK1/2 cascade inhibition and DCLK1 expression in human pancreatic cancer cells and confirmed our results with microarray data generated by other groups in treated colon cancer cell lines (Figure 4D & Additional file1: Figure S2F). Here, DCLK1 is linked to malignant colon neoplasm.